Actively Recruiting

All Genders
ID07335315

Evaluation of Intraoperative Contrast Enhanced Ultrasound for Identifying Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Led by Mayo Clinic · Updated on 2026-01-13

110

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Mayo Clinic

Lead Sponsor

A

American Society of Head and Neck Radiology

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a new imaging technique using contrast enhanced ultrasound during surgery to better identify pituitary adenomas in patients with Cushing disease and other pituitary tumors. This first-in-humans pilot study aims to determine if this approach can help surgeons remove tumors more precisely while preserving normal pituitary tissue, potentially improving clinical outcomes. The study may lead to a larger, multi-center clinical trial if successful. Participants undergoing transsphenoidal pituitary surgery will be divided into two groups. One group will receive contrast enhanced intraoperative ultrasound imaging using Definity microbubbles administered intravenously, with imaging performed in transverse and sagittal planes. The other group will have intraoperative ultrasound without contrast. All participants will also have pre-operative contrast enhanced pituitary MRI and non-contrast intraoperative ultrasound performed as part of their evaluation. During the study, researchers will score and compare the quality of non-contrast ultrasound, contrast enhanced ultrasound, and MRI images to assess their ability to identify pituitary lesions. Participants will undergo standard surgical procedures with added imaging tests, and researchers will monitor imaging results to evaluate the diagnostic value of the contrast technique. The study is observational and will continue until January 2027.

CONDITIONS

Brief Title

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Cushing disease or non-corticotroph pituitary adenoma requiring surgery
  • Scheduled for transsphenoidal pituitary resection
  • Agree to undergo transsphenoidal surgical resection
  • Patients undergoing any pituitary surgery with designated neurosurgeons requiring intraoperative ultrasound without contrast
  • Able to give informed consent
Not Eligible

You will not qualify if you...

  • Unable to consent or legal guardian declines consent
  • Known or suspected allergy to microbubble contrast agents or components like polyethylene glycol (PEG)
  • Women of child-bearing potential with positive pregnancy test before procedure
  • Presence of right to left, bi-directional, or transient right to left cardiac shunts
  • Known allergy to perflutren
  • For non-contrast group, unable to consent or legal guardian declines consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for consent and eligibility assessment

Diagnostic Evaluation

Duration - Day of surgery

Participants undergo pre-operative contrast enhanced pituitary MRI and intraoperative ultrasound imaging with or without contrast during their scheduled pituitary surgery.

1 surgical visit including imaging procedures

Long-term Monitoring

Duration - Up to several weeks post-surgery as per routine care

Participants are observed following surgery to assess outcomes and safety.

Approximately 1 to 2 post-operative visits

Trial Site Locations

Total: 1 location

1

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

N

Neurologic Surgery Research Department

I

Ian Mark, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Phase 1b/2a Open-label Multiple-ascending Dose Study of CR...

Cushing Syndrome

Actively Recruiting

1 location

A Twenty-years' Experience in Pituitary Disease: Identificat...

Pituitary Adenoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here